世界のナトリウム/グルコース共輸送体2(SGLT 2)阻害薬市場2021:メーカー別・地域別・種類別・用途別市場予測(~2026)

GlobalInfoResearchが発行した調査報告書(GIR21MY19212)
◆英語タイトル:Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
◆商品コード:GIR21MY19212
◆発行会社(リサーチ会社):GlobalInfoResearch
◆発行日:2021年5月
◆ページ数:109
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後2~3日)
◆調査対象地域:グローバル
◆産業分野:Pharma & Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥382,800見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥574,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalInfoResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。

GlobalInfoResearch社の本調査レポートでは、ナトリウム/グルコース共輸送体2(SGLT 2)阻害薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。ナトリウム/グルコース共輸送体2(SGLT 2)阻害薬の種類別市場規模(Invokana(カナグリフロジン)、Jardiance(エンパグリフロジン)、Farxiga / Forxiga(ダパグリフロジン)、Suglat(イプラグリフロジン))、用途別市場規模(病院、医療研究所、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・メーカー情報(企業概要、製品概要、販売量、価格、売上):Eli Lilly、Janssen Pharmaceuticals、Astellas、Boehringer Ingelheim、AstraZeneca、Bristol Myers Squibb、Kotobuki Pharmaceutical
・メーカー別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年:Invokana(カナグリフロジン)、Jardiance(エンパグリフロジン)、Farxiga / Forxiga(ダパグリフロジン)、Suglat(イプラグリフロジン)
・用途別分析2016年-2026年:病院、医療研究所、その他
・ナトリウム/グルコース共輸送体2(SGLT 2)阻害薬の北米市場規模2016年-2026年:アメリカ、カナダ、メキシコ
・ナトリウム/グルコース共輸送体2(SGLT 2)阻害薬のヨーロッパ市場規模2016年-2026年:ドイツ、イギリス、フランス、ロシア、イタリア
・ナトリウム/グルコース共輸送体2(SGLT 2)阻害薬のアジア市場規模2016年-2026年:中国、日本、韓国、インド、東南アジア、オーストラリア
・ナトリウム/グルコース共輸送体2(SGLT 2)阻害薬の南米市場規模2016年-2026年:ブラジル、アルゼンチン
・ナトリウム/グルコース共輸送体2(SGLT 2)阻害薬の中東・アフリカ市場規模2016年-2026年:サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論
【レポートの概要】

The Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Invokana (Canagliflozin)
Jardiance (Empagliflozin)
Farxiga/Forxiga (Dapagliflozin)
Suglat (Ipragliflozin)

Market segment by Application can be divided into
Hospital
Medical Research Institute
Other

The key market players for global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors market are listed below:
Eli Lilly
Janssen Pharmaceuticals
Astellas
Boehringer Ingelheim
AstraZeneca
Bristol Myers Squibb
Kotobuki Pharmaceutical

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

【レポートの目次】

1 Market Overview
1.1 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Invokana (Canagliflozin)
1.2.3 Jardiance (Empagliflozin)
1.2.4 Farxiga/Forxiga (Dapagliflozin)
1.2.5 Suglat (Ipragliflozin)
1.3 Market Analysis by Application
1.3.1 Overview: Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Medical Research Institute
1.3.4 Other
1.4 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size & Forecast
1.4.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales in Value (2016-2026))
1.4.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales in Volume (2016-2026)
1.4.3 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Price by Type (2016-2026) & (USD/Kg)
1.5 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production Capacity Analysis
1.5.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Total Production Capacity (2016-2026)
1.5.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Drivers
1.6.2 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Restraints
1.6.3 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Trends Analysis
2 Manufacturers Profiles
2.1 Eli Lilly
2.1.1 Eli Lilly Details
2.1.2 Eli Lilly Major Business
2.1.3 Eli Lilly Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product and Services
2.1.4 Eli Lilly Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Janssen Pharmaceuticals
2.2.1 Janssen Pharmaceuticals Details
2.2.2 Janssen Pharmaceuticals Major Business
2.2.3 Janssen Pharmaceuticals Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product and Services
2.2.4 Janssen Pharmaceuticals Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Astellas
2.3.1 Astellas Details
2.3.2 Astellas Major Business
2.3.3 Astellas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product and Services
2.3.4 Astellas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Boehringer Ingelheim
2.4.1 Boehringer Ingelheim Details
2.4.2 Boehringer Ingelheim Major Business
2.4.3 Boehringer Ingelheim Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product and Services
2.4.4 Boehringer Ingelheim Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 AstraZeneca
2.5.1 AstraZeneca Details
2.5.2 AstraZeneca Major Business
2.5.3 AstraZeneca Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product and Services
2.5.4 AstraZeneca Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Bristol Myers Squibb
2.6.1 Bristol Myers Squibb Details
2.6.2 Bristol Myers Squibb Major Business
2.6.3 Bristol Myers Squibb Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product and Services
2.6.4 Bristol Myers Squibb Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Kotobuki Pharmaceutical
2.7.1 Kotobuki Pharmaceutical Details
2.7.2 Kotobuki Pharmaceutical Major Business
2.7.3 Kotobuki Pharmaceutical Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product and Services
2.7.4 Kotobuki Pharmaceutical Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Manufacturer
3.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors
3.4 Market Concentration Rate
3.4.1 Top 3 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Manufacturer Market Share
3.4.2 Top 6 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Manufacturer Market Share
3.5 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size by Region
4.1.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales in Volume by Region (2016-2026)
4.1.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Region (2016-2026)
4.2 North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue (2016-2026)
4.3 Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue (2016-2026)
4.4 Asia-Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue (2016-2026)
4.5 South America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue (2016-2026)
4.6 Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales in Volume by Type (2016-2026)
5.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Type (2016-2026)
5.3 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales in Volume by Application (2016-2026)
6.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Application (2016-2026)
6.3 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Type (2016-2026)
7.2 North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application (2016-2026)
7.3 North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size by Country
7.3.1 North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales in Volume by Country (2016-2026)
7.3.2 North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Type (2016-2026)
8.2 Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application (2016-2026)
8.3 Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size by Country
8.3.1 Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales in Volume by Country (2016-2026)
8.3.2 Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Type (2016-2026)
9.2 Asia-Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application (2016-2026)
9.3 Asia-Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size by Region
9.3.1 Asia-Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Type (2016-2026)
10.2 South America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application (2016-2026)
10.3 South America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size by Country
10.3.1 South America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales in Volume by Country (2016-2026)
10.3.2 South America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Type (2016-2026)
11.2 Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application (2016-2026)
11.3 Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size by Country
11.3.1 Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Typical Distributors
12.3 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Type, (USD Million), 2021-2026
Table 2. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Application, (USD Million), 2021-2026
Table 3. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 4. Eli Lilly Major Business
Table 5. Eli Lilly Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product and Services
Table 6. Eli Lilly Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (Kg), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Janssen Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 8. Janssen Pharmaceuticals Major Business
Table 9. Janssen Pharmaceuticals Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product and Services
Table 10. Janssen Pharmaceuticals Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (Kg), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Astellas Basic Information, Manufacturing Base and Competitors
Table 12. Astellas Major Business
Table 13. Astellas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product and Services
Table 14. Astellas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (Kg), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 16. Boehringer Ingelheim Major Business
Table 17. Boehringer Ingelheim Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product and Services
Table 18. Boehringer Ingelheim Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (Kg), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 20. AstraZeneca Major Business
Table 21. AstraZeneca Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product and Services
Table 22. AstraZeneca Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (Kg), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Bristol Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 24. Bristol Myers Squibb Major Business
Table 25. Bristol Myers Squibb Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product and Services
Table 26. Bristol Myers Squibb Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (Kg), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Kotobuki Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 28. Kotobuki Pharmaceutical Major Business
Table 29. Kotobuki Pharmaceutical Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product and Services
Table 30. Kotobuki Pharmaceutical Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (Kg), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Manufacturer (2019-2021e) & (Kg)
Table 32. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 33. Market Position of Manufacturers in Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 34. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production Capacity by Company, (Kg): 2020 VS 2021
Table 35. Head Office and Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production Site of Key Manufacturer
Table 36. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Region (2016-2021e) & (Kg)
Table 37. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Region (2021-2026) & (Kg)
Table 38. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Region (2016-2021e) & (USD Million)
Table 39. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Region (2021-2026) & (USD Million)
Table 40. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Type (2016-2021e) & (Kg)
Table 41. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Type (2021-2026) & (Kg)
Table 42. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Type (2016-2021e) & (USD Million)
Table 43. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Type (2021-2026) & (USD Million)
Table 44. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Price by Type (2016-2021e) & (USD/Kg)
Table 45. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Price by Type (2021-2026) & (USD/Kg)
Table 46. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application (2016-2021e) & (Kg)
Table 47. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application (2021-2026) & (Kg)
Table 48. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Application (2016-2021e) & (USD Million)
Table 49. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Application (2021-2026) & (USD Million)
Table 50. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Price by Application (2016-2021e) & (USD/Kg)
Table 51. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Price by Application (2021-2026) & (USD/Kg)
Table 52. North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Country (2016-2021e) & (Kg)
Table 53. North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Country (2021-2026) & (Kg)
Table 54. North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Country (2016-2021e) & (USD Million)
Table 55. North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Country (2021-2026) & (USD Million)
Table 56. North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Type (2016-2021e) & (Kg)
Table 57. North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Type (2021-2026) & (Kg)
Table 58. North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application (2016-2021e) & (Kg)
Table 59. North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application (2021-2026) & (Kg)
Table 60. Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Country (2016-2021e) & (Kg)
Table 61. Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Country (2021-2026) & (Kg)
Table 62. Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Country (2016-2021e) & (USD Million)
Table 63. Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Country (2021-2026) & (USD Million)
Table 64. Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Type (2016-2021e) & (Kg)
Table 65. Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Type (2021-2026) & (Kg)
Table 66. Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application (2016-2021e) & (Kg)
Table 67. Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application (2021-2026) & (Kg)
Table 68. Asia-Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Region (2016-2021e) & (Kg)
Table 69. Asia-Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Region (2021-2026) & (Kg)
Table 70. Asia-Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Region (2016-2021e) & (USD Million)
Table 71. Asia-Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Region (2021-2026) & (USD Million)
Table 72. Asia-Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Type (2016-2021e) & (Kg)
Table 73. Asia-Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Type (2021-2026) & (Kg)
Table 74. Asia-Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application (2016-2021e) & (Kg)
Table 75. Asia-Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application (2021-2026) & (Kg)
Table 76. South America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Country (2016-2021e) & (Kg)
Table 77. South America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Country (2021-2026) & (Kg)
Table 78. South America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Country (2016-2021e) & (USD Million)
Table 79. South America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Country (2021-2026) & (USD Million)
Table 80. South America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Type (2016-2021e) & (Kg)
Table 81. South America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Type (2021-2026) & (Kg)
Table 82. South America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application (2016-2021e) & (Kg)
Table 83. South America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application (2021-2026) & (Kg)
Table 84. Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Country (2016-2021e) & (Kg)
Table 85. Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Country (2021-2026) & (Kg)
Table 86. Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Country (2016-2021e) & (USD Million)
Table 87. Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Country (2021-2026) & (USD Million)
Table 88. Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Type (2016-2021e) & (Kg)
Table 89. Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Type (2021-2026) & (Kg)
Table 90. Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application (2016-2021e) & (Kg)
Table 91. Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application (2021-2026) & (Kg)
Table 92. Direct Channel Pros & Cons
Table 93. Indirect Channel Pros & Cons
Table 94. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Typical Distributors
Table 95. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Typical Customers
List of Figures
Figure 1. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Picture
Figure 2. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Type in 2020
Figure 3. Invokana (Canagliflozin)
Figure 4. Jardiance (Empagliflozin)
Figure 5. Farxiga/Forxiga (Dapagliflozin)
Figure 6. Suglat (Ipragliflozin)
Figure 7. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Application in 2020
Figure 8. Hospital
Figure 9. Medical Research Institute
Figure 10. Other
Figure 11. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size, (USD Million) & (Kg): 2020 VS 2021 VS 2026
Figure 12. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Forecast (2016-2026) & (USD Million)
Figure 13. United States Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Canada Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Mexico Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Germany Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. France Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. United Kingdom Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Russia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Italy Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Japan Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Korea Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. India Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Southeast Asia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Australia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Brazil Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Egypt Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Saudi Arabia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. South Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Turkey Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (2016-2026) & (Kg)
Figure 33. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production Capacity (2016-2026) & (Kg)
Figure 34. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production Capacity by Geographic Region: 2020 VS 2021
Figure 35. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Drivers
Figure 36. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Restraints
Figure 37. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Trends
Figure 38. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Manufacturer in 2020
Figure 39. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Manufacturer in 2020
Figure 40. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 41. Top 3 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Manufacturer (Revenue) Market Share in 2020
Figure 42. Top 6 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Manufacturer (Revenue) Market Share in 2020
Figure 43. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Region (2016-2026)
Figure 44. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Region (2016-2026)
Figure 45. North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue (2016-2026) & (USD Million)
Figure 46. Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue (2016-2026) & (USD Million)
Figure 47. Asia-Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue (2016-2026) & (USD Million)
Figure 48. South America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue (2016-2026) & (USD Million)
Figure 49. Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue (2016-2026) & (USD Million)
Figure 50. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Type (2016-2026)
Figure 51. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Type (2016-2026)
Figure 52. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Price by Type (2016-2026) & (USD/Kg)
Figure 53. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Application (2016-2026)
Figure 54. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Application (2016-2026)
Figure 55. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Price by Application (2016-2026) & (USD/Kg)
Figure 56. North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Country (2016-2026)
Figure 57. North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Country (2016-2026)
Figure 58. North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Type (2016-2026)
Figure 59. North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Application (2016-2026)
Figure 60. Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Country (2016-2026)
Figure 61. Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Country (2016-2026)
Figure 62. Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Type (2016-2026)
Figure 63. Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Application (2016-2026)
Figure 64. Asia-Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Region (2016-2026)
Figure 67. Asia-Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Application (2016-2026)
Figure 68. South America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Country (2016-2026)
Figure 69. South America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Country (2016-2026)
Figure 70. South America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Type (2016-2026)
Figure 71. South America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Application (2016-2026)
Figure 72. Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Country (2016-2026)
Figure 74. Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Type (2016-2026)
Figure 75. Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Application (2016-2026)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
Figure 77. Methodology
Figure 78. Research Process and Data Source


【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のナトリウム/グルコース共輸送体2(SGLT 2)阻害薬市場2021:メーカー別・地域別・種類別・用途別市場予測(~2026)(Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆